In patients with anaplastic gliomas, 50% (3/6) of tumors progressing to GBM upon recurrence were IDH1 mutated and 30% (3/10) of tumors without malignant transformation upon recurrence had IDH1 mutation (p = 0.607). The gene discussed is IDH1; the disease is glioblastoma.